Is Alzheimer’s Disease Genetic? Understanding Family History and Risk

So, is Alzheimer’s disease genetic? Partly. But the relationship between genes and Alzheimer’s is more nuanced than a simple yes-or-no answer.

This guide explains how inherited genes influence Alzheimer’s risk and what you can do with that information. Whether your parent, grandparent, or sibling had Alzheimer’s, understanding your family history can help put your risk in context.

Is Alzheimer’s Disease Genetic? What the Science Shows

Genes influence Alzheimer’s risk, but they seldom act alone. The role of genetics differs between rare inherited forms and the much more common late-onset form.

Early-Onset Alzheimer’s and Inherited Mutations:

Early-onset Alzheimer’s begins before age 65. In a small subset, inherited mutations in three genes can directly cause the disease:

1. APP

2. PSEN1

3. PSEN2

When a parent carries one of these mutations, each child has a 50% chance of inheriting it. Researchers also study childhood Alzheimer’s disease, a far rarer picture driven by different inherited conditions.

Even among people with early-onset Alzheimer’s, however, only a minority have a mutation in one of these three genes. Most cases do not have this clear-cut inherited cause, which is why having Alzheimer’s family history does not necessarily mean the disease will be passed down.

Late-Onset Alzheimer’s and Genetic Risk:

Late-onset Alzheimer’s begins at age 65 or later. It also accounts for the large majority of cases. Here, genes generally influence risk rather than directly causing the disease. APOE ε4 is the best-known genetic risk variant, but carrying it does not mean a person will develop Alzheimer’s.

Consider genetic risk as changing the odds rather than determining the outcome. Age remains the strongest known risk factor overall. In the United States, more than 7 million people aged 65 and older are living with Alzheimer’s disease.

How Does the APOE Gene Change Your Risk?

The APOE gene has three common variants: ε2, ε3, and ε4. ε3 is the most common and is generally considered the reference level for risk. ε2 may lower Alzheimer’s risk, while ε4 increases it.

According to the National Institute on Aging, about 25% of people carry one ε4 copy, and only about 2% to 3% carry two copies. One ε4 copy is associated with roughly two to three times the risk of Alzheimer’s. The exact effect varies among individuals and populations.

Even so, carrying an ε4 copy does not mean a person will develop Alzheimer’s. Many people with Alzheimer’s do not carry ε4 either. Other genes also influence Alzheimer’s risk, although their effects vary.

This table shows how the main genetic factors differ:

Is Alzheimer’s Hereditary?

Rarely, if you mean a specific gene mutation passed from parent to child that directly causes the disease. This happens in familial Alzheimer’s disease, which can result from mutations in APP, PSEN1, or PSEN2.

Genetic is a broader term. It means genes can affect a person’s risk of developing Alzheimer’s. Late-onset Alzheimer’s is genetic in this sense because certain gene variants can raise or lower risk without directly causing the disease.

Most cases are sporadic, meaning no single inherited mutation directly causes them.

Is Alzheimer’s Inherited from Mother or Father?

Either parent can pass a disease-causing mutation to a child. The rare mutations linked to early-onset Alzheimer’s are on non-sex chromosomes, so either a mother or father can pass them on. Each child has a 50% chance of inheriting the mutation if a parent carries it.

APOE works similarly. You inherit one APOE copy from each parent, so both can contribute to your genetic risk. Researchers have also studied whether having a mother with Alzheimer’s affects risk differently than having a father with the disease. Results are mixed, so there is no clear rule that Alzheimer’s is more likely to come from one parent.

Women make up nearly two-thirds of Americans living with Alzheimer’s. This is partly because women tend to live longer, although researchers are also studying biological differences.

Does Alzheimer’s Family History Increase Your Risk?

A family history of Alzheimer’s can be more concerning when several close relatives are affected or when the disease begins at a younger age.

These details can help your doctor assess your risk:

• Each relative’s age when diagnosed.
• How many relatives are affected and how closely they are related to you.
• Whether a clinician confirmed each diagnosis.
• Any relatives who developed symptoms before age 65.

Should You Get Genetic Testing if Alzheimer’s Runs in Your Family?

Genetic testing is not recommended for most people who have a family history of Alzheimer’s. Tests such as APOE can show whether you carry a higher-risk variant, but they cannot tell you if or when you will develop the disease.

With no cure and limited ways to act on the result, knowing your genetic risk may cause anxiety or emotional distress without providing a clear benefit.

Testing may only be considered when several family members developed Alzheimer’s at a young age or when considering certain anti-amyloid therapies. A genetic counselor can help you understand whether testing is appropriate and what the results could mean.

How Can You Lower Risk When Alzheimer’s Runs in Your Family?

You cannot change your genes, but you can address some factors linked to dementia risk. The 2024 Lancet Commission estimated that addressing 14 modifiable risk factors may help prevent or delay up to 45% of dementia cases worldwide.

Habits with the strongest support include:

• Treating high blood pressure and high cholesterol.
• Correcting hearing and vision loss.
• Staying physically active.
• Avoiding smoking.
• Maintaining regular social contact.
• Getting treatment for depression.

These steps also overlap with Alzheimer’s disease self-care.

How Is Research Changing What We Know About Alzheimer’s Genetics?

Scientists are studying how genes interact with lifestyle and other factors to shape Alzheimer’s risk. This research includes people with different genetic and family histories.

Some researchers are also studying whether early signs of Alzheimer’s in the eye could help identify Alzheimer’s risk before memory symptoms appear. Research on agitation in Alzheimer’s clinical trials is also exploring ways to better manage distress and improve care.

Together, these studies may help us understand where new prevention or treatment strategies may help.